MétaCan
Menu
← Back to cohort
Record W2790677661 · doi:10.1093/jcag/gwy008.176

A175 CAN HCV CORE ANTIGEN REPLACE HCV RNA TESTING IN THE ERA OF DIRECT-ACTING ANTIVIRALS?

2018· article· en· W2790677661 on OpenAlexaff
Marjolein van Tilborg, Raoel Maan, Johannes Vermehren, Benjamin Maasoumy, Tony Mazzulli, Andrés Duarte‐Rojo, Matthew Kowgier, Harry L.A. Janssen, Robert J. de Knegt, Jean–Michel Pawlotsky, Gavin Cloherty, Christoph Sarrazin, Heiner Wedemeyer, Jordan J. Feld

Bibliographic record

VenueJournal of the Canadian Association of Gastroenterology · 2018
Typearticle
Languageen
FieldMedicine
TopicHepatitis C virus research
Canadian institutionsUniversity Health NetworkUniversity of Toronto
Fundersnot available
KeywordsMedicineHepatitis C virusViremiaRegimenSofosbuvirFlaviviridaeInternal medicineHepacivirusHepatitis CVirologyGastroenterologyPegylated interferonImmunologyVirusRibavirin

Abstract

fetched live from OpenAlex

Potent direct-acting antivirals (DAAs) for treatment of chronic hepatitis C virus (HCV) infection have reduced the need for on-treatment monitoring. Currently, on-treatment response and outcome are determined by HCV RNA testing. A less expensive alternative to verify viral replication is HCV core antigen (HCV Ag). The aim of this study was to determine if HCV Ag can be used for initial confirmation of viremia, on-treatment monitoring and determination of SVR in patients with chronic HCV infection receiving DAA treatment. To evaluate the role of HCV Ag in confirming SVR, patients treated with DAAs ±Peg-interferon (IFN)/RBV were included, for the purpose of assessing HCV Ag to determine relapse, patients treated with any regimen (including Peg-IFN/RBV) were included. Serum HCV RNA and HCV Ag levels were assessed at baseline (BL), on-treatment (OT), end of treatment (EOT) and week 12 and/or 24 of follow up (FU). HCV RNA was considered the gold standard. In total, 181 patients were included, 112 (62%) of whom achieved SVR. Mean age was 54 years (19–79), 115 (64%) patients were male. The majority of patients was infected with genotype 1 (68%) and treated with a sofosbuvir-based regimen (58%). Median HCV RNA level at BL was 6.1 Log10 IU/mL (2.7–7.4) and HCV Ag level was 2409 fmol/L (0.85-20000). At BL, 165 out of 167 (98.8%) viremic patients tested positive for HCV Ag. Of the two patients who tested HCV Ag negative, one patient had a low RNA level (2.67 log10 IU/mL), whereas in the second patient HCV RNA level was high (6.38 log10 IU/mL). Baseline HCV Ag and HCV RNA levels were significantly correlated (R=0.87, p<0.001). At treatment week 4, HCV Ag levels had declined in all patients compared to baseline and were negative in 73%. HCV Ag at EOT was positive in 3 (2.7%) patients, all of whom achieved SVR; all were grey zone reactive (3–10 fmol/L). At week 12 FU, in one out of 68 patients (1.5%) who relapsed according to HCV RNA testing (3.11 log10 IU/mL) HCV Ag was not detected. This patient was therefore misdiagnosed as having an SVR by HCV Ag testing. Our data support an algorithm of testing anti-HCV antibody (Ab) positive patients with HCV Ag, reserving HCV RNA for those who are Ab positive but Ag negative. HCV Ag can be used to confirm treatment adherence but may not be adequate for confirmation of SVR, which should still be done by HCV RNA. EOT testing with either test was of little clinical benefit. Assuming current practice involves HCV RNA testing at BL, OT, EOT and SVR, use of HCV Ag could eliminate 75% of HCV RNA tests. Abbott

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.013
metaresearch head score (Gemma)0.028
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.013
Threshold uncertainty score0.067

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0130.028
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0020.001
Bibliometrics0.0010.001
Science and technology studies0.0010.003
Scholarly communication0.0020.007
Open science0.0010.001
Research integrity0.0050.003
Insufficient payload (model declined to judge)0.0070.004

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.041
GPT teacher head0.307
Teacher spread0.266 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2018
Admission routes1
Has abstractyes

Explore more

Same venueJournal of the Canadian Association of Gastroenterology→Same topicHepatitis C virus research→French-language works237,207→